GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $56,209,000 | +6.2% | 1,290,109 | +6.2% | 0.02% | +25.0% |
Q1 2022 | $52,927,000 | +32.4% | 1,214,377 | +34.2% | 0.02% | +45.5% |
Q4 2021 | $39,976,000 | +38.7% | 904,936 | +20.0% | 0.01% | +22.2% |
Q3 2021 | $28,814,000 | -28.1% | 754,256 | -24.9% | 0.01% | -25.0% |
Q2 2021 | $40,093,000 | -36.5% | 1,004,705 | -41.2% | 0.01% | -42.9% |
Q1 2021 | $63,148,000 | -20.7% | 1,708,042 | -21.2% | 0.02% | -25.0% |
Q4 2020 | $79,583,000 | -30.5% | 2,167,368 | -28.3% | 0.03% | -40.4% |
Q3 2020 | $114,534,000 | -14.1% | 3,024,286 | -7.7% | 0.05% | -17.5% |
Q2 2020 | $133,258,000 | +1.0% | 3,277,588 | -4.8% | 0.06% | -17.4% |
Q1 2020 | $131,950,000 | -5.6% | 3,441,846 | +16.0% | 0.07% | +19.0% |
Q4 2019 | $139,756,000 | +16.5% | 2,965,946 | +5.6% | 0.06% | +7.4% |
Q3 2019 | $119,978,000 | +130.2% | 2,807,957 | +112.6% | 0.05% | +134.8% |
Q2 2019 | $52,130,000 | -2.1% | 1,320,804 | +3.7% | 0.02% | -4.2% |
Q1 2019 | $53,222,000 | +43.8% | 1,273,314 | +31.7% | 0.02% | +26.3% |
Q4 2018 | $37,012,000 | -10.6% | 966,699 | +2.0% | 0.02% | +35.7% |
Q3 2018 | $41,387,000 | +14.6% | 947,927 | +5.9% | 0.01% | -12.5% |
Q2 2018 | $36,118,000 | -0.9% | 895,235 | -3.8% | 0.02% | 0.0% |
Q1 2018 | $36,432,000 | -39.4% | 930,224 | -45.1% | 0.02% | -40.7% |
Q4 2017 | $60,093,000 | -19.9% | 1,693,742 | -8.7% | 0.03% | -25.0% |
Q3 2017 | $75,028,000 | +0.4% | 1,855,142 | +7.1% | 0.04% | -2.7% |
Q2 2017 | $74,756,000 | -52.6% | 1,732,508 | -53.3% | 0.04% | -54.9% |
Q1 2017 | $157,760,000 | +5.0% | 3,713,030 | -5.3% | 0.08% | 0.0% |
Q4 2016 | $150,224,000 | -1.0% | 3,921,497 | +11.5% | 0.08% | -3.5% |
Q3 2016 | $151,700,000 | +14.2% | 3,516,450 | +15.7% | 0.08% | +9.0% |
Q2 2016 | $132,800,000 | +34.9% | 3,038,134 | +24.7% | 0.08% | +32.2% |
Q1 2016 | $98,463,000 | +29.9% | 2,435,441 | +29.8% | 0.06% | +34.1% |
Q4 2015 | $75,796,000 | +14.2% | 1,876,299 | +8.7% | 0.04% | +7.3% |
Q3 2015 | $66,378,000 | +12.3% | 1,726,593 | +21.1% | 0.04% | +20.6% |
Q2 2015 | $59,126,000 | -7.3% | 1,425,655 | +3.2% | 0.03% | -8.1% |
Q1 2015 | $63,770,000 | +48.6% | 1,381,633 | +37.7% | 0.04% | +48.0% |
Q4 2014 | $42,902,000 | -3.4% | 1,003,205 | +3.8% | 0.02% | -7.4% |
Q3 2014 | $44,418,000 | -6.4% | 966,086 | +8.9% | 0.03% | -3.6% |
Q2 2014 | $47,464,000 | +5.0% | 887,169 | +4.8% | 0.03% | +3.7% |
Q1 2014 | $45,217,000 | -75.1% | 846,173 | -75.1% | 0.03% | -75.5% |
Q4 2013 | $181,710,000 | +5.8% | 3,403,161 | -0.6% | 0.11% | -2.7% |
Q3 2013 | $171,777,000 | +4.3% | 3,423,637 | +3.9% | 0.11% | -0.9% |
Q2 2013 | $164,690,000 | – | 3,295,513 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |